• 1. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 2. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

• Catalysts and Inorganic Chemicals Inorganic Compounds Homogeneous non-metal compounds Homogeneous other non-metal compounds

Introduction to 2-chloro-4-(3-chlorophenyl)benzonitrile (CAS No. 1355247-47-0)

2-chloro-4-(3-chlorophenyl)benzonitrile, identified by its Chemical Abstracts Service (CAS) number 1355247-47-0, is a significant compound in the realm of pharmaceutical and chemical research. This benzonitrile derivative, featuring chloro substituents on both the phenyl ring and the benzene core, has garnered attention due to its structural versatility and potential applications in medicinal chemistry. The presence of two chlorine atoms enhances its reactivity, making it a valuable intermediate in synthesizing various bioactive molecules.

The compound's structure consists of a benzonitrile group attached to a phenyl ring that is further substituted with a chloro group at the 3-position. This specific arrangement imparts unique electronic and steric properties, which are critical for its role in drug discovery and development. The chloro groups not only influence the compound's solubility and stability but also serve as handles for further functionalization, enabling chemists to design more complex molecules.

In recent years, 2-chloro-4-(3-chlorophenyl)benzonitrile has been explored as a key building block in the synthesis of small-molecule inhibitors targeting various biological pathways. Its incorporation into drug-like scaffolds has shown promise in preclinical studies, particularly in the inhibition of enzymes involved in cancer metabolism. The benzonitrile moiety, known for its ability to interact with biological targets through hydrogen bonding and π-stacking interactions, plays a crucial role in enhancing binding affinity and selectivity.

One of the most compelling aspects of 2-chloro-4-(3-chlorophenyl)benzonitrile is its utility in generating libraries of compounds for high-throughput screening (HTS). Researchers have leveraged its structural features to develop novel analogs with improved pharmacokinetic profiles. For instance, modifications at the 2- and 4-positions have been investigated to optimize solubility, metabolic stability, and target engagement. These efforts have led to the identification of several lead compounds that are currently undergoing further optimization.

The compound's reactivity also makes it a valuable tool in synthetic organic chemistry. It can undergo various transformations, including nucleophilic aromatic substitution (SNAr), cross-coupling reactions, and cyclization processes, which are essential for constructing more complex molecular architectures. These synthetic pathways have been employed to generate derivatives with diverse biological activities, including anti-inflammatory, antimicrobial, and anticancer effects.

Recent advancements in computational chemistry have further enhanced the utility of 2-chloro-4-(3-chlorophenyl)benzonitrile. Molecular modeling studies have revealed insights into its interaction with biological targets, providing a rational basis for designing more effective inhibitors. These studies have highlighted the importance of optimizing the electronic distribution within the molecule to improve binding affinity and reduce off-target effects.

The pharmaceutical industry has also shown interest in 2-chloro-4-(3-chlorophenyl)benzonitrile due to its potential as a starting material for producing next-generation therapeutics. Its structural motifs are found in several approved drugs, underscoring its significance in drug discovery. Companies are actively exploring derivatives of this compound as candidates for treating neurological disorders, infectious diseases, and metabolic conditions.

In conclusion, 2-chloro-4-(3-chlorophenyl)benzonitrile (CAS No. 1355247-47-0) represents a versatile and promising compound with broad applications in pharmaceutical research. Its unique structural features and reactivity make it an indispensable tool for chemists and biologists working on drug development. As research continues to uncover new therapeutic targets and synthetic strategies, this compound is poised to play an even greater role in advancing medical science.

• 5435-92-7(2-Chloro-4-phenylbenzonitrile)
• 1237137-24-4(2-chloro-4-(4-chlorophenyl)benzonitrile)
• 1355246-88-6(2-chloro-4-(3,5-dichlorophenyl)benzonitrile)
• 1355248-19-9(2-chloro-4-(3-chloro-4-methylphenyl)benzonitrile)
• 253679-13-9(3-(3-Chloro-4-methylphenyl)benzonitrile)
• 1068162-79-7(2-chloro-4-(3-chloro-4-cyanophenyl)benzonitrile)
• 1355247-42-5(2-chloro-4-(2-chloro-4-methylphenyl)benzonitrile)
• 1355247-45-8(2-chloro-4-(2-chloro-5-methylphenyl)benzonitrile)
• 1349059-34-2(2-Chloro-4-(2-methylphenyl)benzonitrile)
• 1352318-49-0(4-(3-Chloro-4-methylphenyl)benzonitrile)